Amyotrophic Lateral Sclerosis: A Guide for Patients and Families - Couverture souple

Mitsumoto, Hiroshi; Norris, Forbes H.

 
9781888799286: Amyotrophic Lateral Sclerosis: A Guide for Patients and Families

Synopsis

Since publication of the first edition of this book, the understanding and treatment of ALS have changed dramatically. The many puzzles of this disease are being steadily solved. One cause of familial ALS has been identified, and the mechanisms of motor neuron cell death are much better understood. The FDA has approved riluzole, the first drug available for the treatment of ALS. Additional drugs are being tested and others are on the horizon. This comprehensive guide covers every aspect of the management of ALS. Beginning with discussions of clinical features of the disease, diagnosis, and an overview of symptom management. Major sections deal with medical and rehabilitative management, living with ALS, managing advanced disease, end-of-life issues, and resources that can provide support and assistance. Regardless of their views about long-range events, everyone dealing with the reality of ALS wants to know what to do now. Issues that they have or will need to deal with include: * whether to participate in therapeutic trials * the role of rehabilitation treatments * the use of riluzole (Rilutek), as well as new experimental preparations and drugs that have been approved for some other disease and are being used in ALS

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

ALS, also known as """"Lou Gehrig's disease"""", cannot be cured but it can be treated. A great deal can be done by physicians and other health care professionals to treat the symptoms of ALS, to improve the patient?s quality of life, and to help caregivers and families to cope with the disease. This extensively revised and rewritten new edition is specifically addressed to the needs of patients and families living with the reality of ALS. Since publication of the first edition of this book, the understanding and treatment of ALS have changed dramatically. The many puzzles of this disease are being steadily solved. One cause of familial ALS has been identified, and the mechanisms of motor neuron cell death are much better understood. The FDA has approved riluzole, the first drug available for the treatment of ALS. Additional drugs are being tested and others are on the horizon. This comprehensive guide covers every aspect of the management of ALS. Beginning with discussions of clinical features of the disease, diagnosis, and an overview of symptom management. Major sections deal with medical and rehabilitative management, living with ALS, managing advanced disease, end-of-life issues, and resources that can provide support and assistance.

Biographie de l'auteur

Dr. Hiroshi Mitsumoto is the current Medical Director of the ALS Center at Columbia University Medical Center. Previously he was on the faculty of the Cleveland Clinic Foundation where he served as Director of the ALS Center. In 2000 he received the Lou Gehrig Memorial Award from the Muscular Dystrophy Association. He has published widely on the subject.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Autres éditions populaires du même titre

9781932603729: Amyotrophic Lateral Sclerosis: A Guide for Patients and Families

Edition présentée

ISBN 10 :  1932603727 ISBN 13 :  9781932603729
Editeur : Demos Medical Publishing, 2009
Couverture souple